Blue Sky Completes Geophysical Survey at Amarillo Grande Uranium Project & Identifies Anomaly at Ivana Gap Target for Drill Testing

https://mma.prnewswire.com/media/2797591/Blue_Sky_Uranium_Corp__Blue_Sky_Completes_Geophysical_Survey_at.jpg TSX Venture Exchange: BSKFrankfurt Stock Exchange: MAL2OTCQB Venture Market (OTC):BKUCF Blue Sky Uranium Corp. (TSXV: BSK), (FSE: MAL2), (OTC: BKUCF) “Blue Sky” or the “Company”) is pleased to announce that the Company has completed an induced polarization (pole-dipole electrical tomography (“ET”)) geophysical survey at the Ivana Gap target, located between the Company's Ivana Deposit […]

TNL Mediagene (NASDAQ: TNMG) and Geniee Form Strategic Partnership to Expand Access to Advertising Creative Solution “Cr.ED”

The Company's leading Japanese media subsidiary, Mediagene Inc., has formed a strategic partnership with leading Japanese AdTech company Geniee to expand the reach of its successful advertising creative solution Cr.ED Partnership enables wider distribution of the Company's Cr.ED product, a data-powered creative platform and SaaS service that helps marketers create rich and engaging interactive digital

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

(Euronext Growth Paris:ALCLS),(NasdaqGM:CLLS), Event features full Phase 1 data and pivotal Phase 2 strategy for lasme-cel (UCART22) in r/r B-ALL NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today

Verano Elevates Expanding Vape Product Portfolio with Exclusive, First-to-Market Launch of Revolutionary HYPHEN System

(Neo:VRNO.NE),(OTC US:VRNOF),(OtherOTC:VRNOF), HYPHEN features brand new best-in-class technology that allows consumers to flex between extracts, size formats and brands through interchangeable vape pods CHICAGO, Oct. 16, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of HYPHEN, driving further

Gain Therapeutics to Attend the 2025 Maxim Growth Summit

(NasdaqGM:GANX), BETHESDA, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced it will participate in the upcoming 2025 Maxim Growth Summit, taking place from October 22nd to 23rd

Aduro Clean Technologies Reports First Quarter Fiscal 2026 Results and Provides Business Update

(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Oct. 16, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st

VoteMate Launches to Help Every American Vote with Confidence

LOS ANGELES, Oct. 16, 2025 (GLOBE NEWSWIRE) — Voting should be simple. Yet for millions of Americans, understanding a long, complex ballot can feel overwhelming. Today, VoteMate launched to change that: a free, AI-powered, nonprofit, and nonpartisan web app that helps every voter fill out their ballot faster, easier, and with confidence. “When it took

Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases

(NASDAQ:DNTH), DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function Demonstrated superior inhibition of pDCs vs. litifilimab in vitro and superior Ig reductions vs. povetacicept in NHPs highlight the potential for improved clinical benefit in severe autoimmune

Landmark Gallup Study Shows Less Than Half of U.S. Workers Have A Quality Job

National survey of 18,000 workers offers new open source data often missing from typical labor market measures A new nationally representative survey reveals that four in 10 U.S. workers are in jobs that meet the basic elements of job quality, such as providing fair pay, having predictable schedules, and offering opportunities to grow and advance

Mining commences at Kiniero as project tracks towards first gold in Q4 CY2025

(TSX-V:RBX),(AUST:RXR.AU),(AUST:RXR.XA),(Pinksheets:RSRBF),(PinkSheets:RSRBF),(Boerse Frankfurt – Freiverkehr:RB4),(AUST:RXR.AX), Highlights: Robex's Kiniero Gold Project, Guinea, remains on track and budget for first gold pour in Q4 CY25. The Kiniero project remains LTI free (lost time injury) with 4,857,704 hours complete to 30 September 2025. Mine development activities are tracking according to plan; Mining has commenced on day and night shift

Scroll to Top